Voyager Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $15 price target.
Portfolio Pulse from Benzinga Newsdesk
Voyager Therapeutics shares rose after Leerink Partners initiated coverage with an Outperform rating and a $15 price target.
October 16, 2024 | 6:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Voyager Therapeutics shares increased following Leerink Partners' initiation of coverage with an Outperform rating and a $15 price target.
The initiation of coverage by Leerink Partners with an Outperform rating and a $15 price target is a positive signal for investors, likely boosting short-term stock price due to increased investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100